We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/AI

AI

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

AI Radiomics Detects Visually Occult Pancreatic Cancer on CT Nearly 16 Months Before Diagnosis and Outperforms Radiologists
AIComputed tomographyearly detection AI

AI Radiomics Detects Visually Occult Pancreatic Cancer on CT Nearly 16 Months Before Diagnosis and Outperforms Radiologists

By MedXY|May 4, 2026

A multi-institutional AI model identified pre-diagnostic pancreatic cancer on routine CT with meaningful lead time, higher sensitivity than radiologists, longitudinal stability, and externally validated specificity in a low-prevalence setti

AI vs. Human Clinicians: Study Reveals Gaps in AI-Generated Clinical Notes
AIAIartificial intelligence

AI vs. Human Clinicians: Study Reveals Gaps in AI-Generated Clinical Notes

By MedXY|Apr 21, 2026

A cross-sectional evaluation of AI-generated clinical notes found significant quality deficits compared to human-produced notes, particularly in thoroughness, organization, and usefulness.

Adaptive AI Transforms Cardiovascular Event Adjudication: New Algorithm Achieves Near-Human Accuracy Across Multiple Endpoints
AIartificial intelligencecardiovascular events

Adaptive AI Transforms Cardiovascular Event Adjudication: New Algorithm Achieves Near-Human Accuracy Across Multiple Endpoints

By MedXY|Apr 4, 2026

Researchers developed and validated ADAPT-CEC, an artificial intelligence algorithm that can adjudicate cardiovascular events across different trial definitions. A hybrid approach combining AI with selective human review achieved 95.6% accu

Beyond Immersion: Why Combining Action Observation with Virtual Reality is a Game-Changer for Post-Stroke Hand Recovery
AIneuroplasticityQuan Sát Hành Động

Beyond Immersion: Why Combining Action Observation with Virtual Reality is a Game-Changer for Post-Stroke Hand Recovery

By MedXY|Mar 28, 2026

A multicenter randomized controlled trial reveals that integrating action observation with virtual reality significantly improves paretic hand dexterity in stroke patients, with benefits persisting six months post-intervention, offering a s

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography
AIartificial intelligenceECG

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography

By MedXY|Mar 9, 2026

This review evaluates the breakthrough ECG2HF model, a publicly available AI tool that outperforms standard clinical scores in predicting 10-year heart failure risk using 12-lead ECG waveforms.

Breaking the Hardware Barrier: How Domain-Shift AI Enables Vendor-Agnostic 3D OCT Macular Disease Detection
AIartificial intelligencedeep learning

Breaking the Hardware Barrier: How Domain-Shift AI Enables Vendor-Agnostic 3D OCT Macular Disease Detection

By MedXY|Mar 2, 2026

A multicenter study in JAMA Ophthalmology introduces a deep learning model using domain-shift technology to accurately detect macular diseases across different OCT hardware vendors, achieving high negative predictive value and establishing

AI-Supported Mammography Outperforms Standard Double Reading: Insights from the MASAI Trial
AIartificial intelligencebreast cancer screening

AI-Supported Mammography Outperforms Standard Double Reading: Insights from the MASAI Trial

By MedXY|Mar 2, 2026

The MASAI trial demonstrates that AI-supported mammography screening achieves higher sensitivity and non-inferior interval cancer rates compared to standard double reading, while maintaining specificity and significantly reducing radiologis

AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy
AIartificial intelligenceheart failure

AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy

By MedXY|Mar 2, 2026

The TRICORDER trial demonstrates that while AI stethoscopes are capable of detecting heart failure, atrial fibrillation, and valvular disease, their real-world implementation in UK primary care did not yield a statistically significant incr

Telesurgery Breaks the Distance Barrier: Landmark RCT Confirms Non-Inferiority to Local Robotic Urology
AIclinical trialrobotic surgery

Telesurgery Breaks the Distance Barrier: Landmark RCT Confirms Non-Inferiority to Local Robotic Urology

By MedXY|Feb 25, 2026

A multicentre randomized controlled trial demonstrates that robotic telesurgery over distances up to 2800 km is non-inferior to local surgery for urological procedures, maintaining high success rates, low latency, and equivalent safety prof

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias
AIartificial intelligenceophthalmology

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias

By MedXY|Feb 22, 2026

A crossover study involving 30 ophthalmologists and trainees reveals that while Claude-3.5-Sonnet collaboration improves diagnostic accuracy in complex cases, it also increases confidence in incorrect decisions and fails to reach the perfor

Precision Oncology Meets Artificial Intelligence: Navigating Ancestry-Associated Variability in Digital Pathology for EGFR Prediction
AIEGFR mutationGenetic Ancestry

Precision Oncology Meets Artificial Intelligence: Navigating Ancestry-Associated Variability in Digital Pathology for EGFR Prediction

By MedXY|Feb 22, 2026

This review evaluates the generalizability of AI pathology models in predicting EGFR mutations, highlighting significant performance variations across genetic ancestries and specimen types, and their role in clinical triage.

AI Assistant Achieves High Accuracy in Molecular-Based CNS Tumor Classification: A Multi-Institutional Validation
AIartificial intelligencedigital health

AI Assistant Achieves High Accuracy in Molecular-Based CNS Tumor Classification: A Multi-Institutional Validation

By MedXY|Feb 18, 2026

This multi-institutional study validates Neuropath-AI, a deep-learning system that predicts CNS tumor types by inferring molecular features from histopathology slides. Achieving 80% top-1 accuracy in high-confidence samples, the model offer

AI-Driven Detection of Extranodal Extension Outperforms Radiologists in Predicting Outcomes for HPV-Positive Oropharyngeal Cancer
AIartificial intelligenceExtranodal Extension

AI-Driven Detection of Extranodal Extension Outperforms Radiologists in Predicting Outcomes for HPV-Positive Oropharyngeal Cancer

By MedXY|Feb 11, 2026

A single-center study demonstrates that an AI pipeline for CT-based lymph node segmentation and extranodal extension classification significantly improves prognostic accuracy for HPV-positive oropharyngeal cancer compared to traditional rad

High Empathy, Low Accuracy: Can Generative AI Safely Navigate Alcohol Misuse Support?
AIAlcohol Misuseartificial intelligence

High Empathy, Low Accuracy: Can Generative AI Safely Navigate Alcohol Misuse Support?

By MedXY|Feb 2, 2026

A longitudinal study published in NEJM AI evaluates seven generative AI chatbots for alcohol misuse support, finding that while they excel in empathy and non-judgmental language, they frequently provide low-quality or inaccurate medical inf

AI-Driven Prognosis: EEGSurvNet Accurately Predicts Seizure Timing From Routine EEG Data
AIdeep learningEEG

AI-Driven Prognosis: EEGSurvNet Accurately Predicts Seizure Timing From Routine EEG Data

By MedXY|Jan 28, 2026

Researchers developed EEGSurvNet, a deep survival model that analyzes routine EEG to predict seizure risk over two years. Outperforming clinical models, it achieved an AUROC of 0.80 at two months and showed high efficacy in patients without

AI-ECG Models for Heart Failure Screening Show High Accuracy in First-of-its-Kind Independent Comparison Study
AIartificial intelligenceCardiology

AI-ECG Models for Heart Failure Screening Show High Accuracy in First-of-its-Kind Independent Comparison Study

By MedXY|Jan 26, 2026

This independent validation study confirms that AI-enhanced ECG models effectively detect left ventricular systolic dysfunction across diverse populations, achieving AUROCs up to 0.93. However, significant barriers remain regarding model tr

AI-Driven Decision Support for Antibiotic Switching: Why Clinicians Value Caution Over Speed
AIantimicrobial stewardshipartificial intelligence

AI-Driven Decision Support for Antibiotic Switching: Why Clinicians Value Caution Over Speed

By MedXY|Jan 15, 2026

A randomized multimethod study reveals that while AI clinical decision support systems for antibiotic switching are well-received, their primary influence is reinforcing conservative prescribing. The study underscores that usability and cli

Mobile Health Management Model Slashes Gestational Diabetes Incidence by Nearly 45% in High-Risk Pregnancies
AIGestational Diabetesmaternal health

Mobile Health Management Model Slashes Gestational Diabetes Incidence by Nearly 45% in High-Risk Pregnancies

By MedXY|Jan 11, 2026

A randomized controlled trial demonstrates that an mHealth management model using the Better Pregnancy app significantly reduces GDM incidence, improves glycemic control, and enhances maternal self-efficacy among high-risk pregnant women, p

Multimodal AI Outperforms Clinical Nomograms in Predicting Metastasis for Post-Prostatectomy Biochemical Recurrence
AIartificial intelligenceprostate cancer

Multimodal AI Outperforms Clinical Nomograms in Predicting Metastasis for Post-Prostatectomy Biochemical Recurrence

By MedXY|Jan 10, 2026

A validated multimodal AI model using digital pathology and clinical data significantly improves risk stratification for prostate cancer patients with biochemical recurrence, identifying those who derive the greatest benefit from salvage ho

AI-Derived Sarcopenia Metrics Predict Survival Benefit from Anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer
AIartificial intelligencemetastatic colorectal cancer

AI-Derived Sarcopenia Metrics Predict Survival Benefit from Anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer

By MedXY|Jan 8, 2026

A deep learning analysis of the PanaMa trial reveals that the benefit of adding panitumumab to maintenance therapy for RAS wild-type mCRC is significantly higher in patients with a high muscle-bone ratio, suggesting a new AI-driven approach

Prev
3 / 9
12345…9
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles